Navigation Links
New Treatment for 'Lazy Eye' Shows Promise
Date:3/4/2008

U.S., Chinese project finds 90% of vision gains retained 1 year after therapy

TUESDAY, March 4 (HealthDay News) -- A new treatment for lazy eye shows promise in adults, say American and Chinese researchers who found the therapy worked well in 20-year-old volunteers.

Lazy eye, also known as amblyopia, has been considered irreversible after age 8. Many people with the condition, especially those in developing countries, are diagnosed too late for conventional treatment with an eye patch, the researchers noted.

This new method, called perceptual learning, involves training with a simple visual task to improve vision.

A pilot trial at a Beijing hospital found that 28 of 30 patients showed dramatic gains after a 10-day course of treatment with the new method, said research group leader Zhong-Lin Lu, a University of Southern California neuroscientist.

"After training, they start to use both eyes. Some people got to 20/20. By clinical standards, they're completely normal. They're not amblyopes anymore," Lu said in a prepared statement.

The gains among the patients averaged two to three lines on a standard eye chart. Previous research found that the improvement is long-lasting, with 90 percent of vision gain retained at least one year after the therapy.

The research was described in a study published in this week's online issue of the Proceedings of the National Academy of Sciences.

Amblyopia, which can't be corrected with glasses, affects about 3 percent of people. Symptoms of the disorder include poor vision in one eye, poor depth perception, difficulty seeing three-dimensional objects, and poor motion sensitivity. Amblyopia is caused by poor transmission of images from the eye to the brain during early childhood, leading to abnormal brain development, according to background information in a new release about the research.

While this new perceptual learning thera
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. New treatment boosts muscle function in myasthenia gravis
3. Broad-based group of physicians calls for improvement in stroke treatment
4. Cranberry Could Juice Up Ovarian Cancer Treatment
5. Non-medicinal treatment touted for pre-schoolers with ADHD
6. Nonmedicinal treatment touted for preschoolers with ADHD
7. U of M study: Early treatment can reverse heart damage
8. Biologic treatment for rheumatoid arthritis and the risk of cancer
9. New Treatment Explored for Cluster Headaches
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Treatment for 'Lazy Eye' Shows Promise
(Date:7/3/2015)... , ... July 04, 2015 , ... The Harvest Hope Food Bank will ... Four local AlignLife offices in the area of Greenville SC are making it ... be made by patients only. They are asking for donations from the public as well. ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June ... a new SEO training system called "Page One Engine" . The program, ... has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined ...
(Date:7/3/2015)... ... ... Scientists at several top US cancer centers believe they now know why certain ... to read the complete story , just posted on the Surviving Mesothelioma website. ... New York University exposed mice with a mutation on the tumor suppressor gene called ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the ... to lead a national president recruitment for Regional Care, Inc. in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/3/2015)... ... 2015 , ... The Erie County Bar Association Institute of ... Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... these types of cases. , Each year, New York State residents are hospitalized ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... of successful hepatitis C virus (HCV) therapy in African Americans ... the antiviral activity induced by interferon. The study is ... of Infectious Diseases , now available online. , More than ... countries more than 10 percent of the population is infected. ...
... some groups, survival odds after angioplasty are not as ... major international study pinpoints which people with major heart ... than artery-opening angioplasty. , "Bypass surgery is preferable for ... Hlatky, professor of health research and policy and cardiovascular ...
... of Interest Tracking Helps Mainstream Management ProcessSTUART, Fla., ... Health Systems, a not-for-profit, community-based healthcare organization covering ... track potential conflicts of interests for its board ... healthcare system based in a moderately sized community, ...
... Barbara, California, offshore oil spill gave birth to new ... in environmental protection worldwide. Since then, environmental regulation has ... performance and has contributed to a deepening confrontation between ... of politics and society. , In his new ...
... Healthcare Conference and Expo will provide employers and health ... during a June 1-3, 2009 conference in Kansas City, ... employer rather than a conference promoter. Deffenbaugh,s ... event to help educate employers and plan sponsors on ...
... at Uppsala University, together with colleagues at the Karolinska ... the genes the determine the dosage of the blood-thinning ... journal PLoS Genetics . , "We have previously ... that we have gone in and scanned the entire ...
Cached Medicine News:Health News:2-day results predict ultimate response to therapy in chronic hepatitis C 2Health News:Diabetics and Elderly May Fare Better With Bypass 2Health News:Diabetics and Elderly May Fare Better With Bypass 3Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 2Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 3Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 4Health News:MediTract's Compliance Management Tools Improve Efficiencies at Martin Memorial Health Systems 5Health News:An even-handed analysis of environmental policy 2Health News:Deffenbaugh Industries to Host Self-Funding Healthcare Conference in Kansas City 2
(Date:7/2/2015)... 2, 2015 Roche,s Bloodhound technology is ... segment in hematology testing, according to Kalorama Information.  ... unveiling of its Bloodhound digital cell imaging technology ... 511 hematology analyzer – is notable as ... by current leader CellaVision, but also compete more ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has ... Analog, Application, End-User & by Region - Global Trends & ... This market is projected to reach about $2.5 Million by ... and rising opportunities in countries such as India ... , and Brazil . In 2013, ...
(Date:7/2/2015)... --  EVO Aesthetic Center and Wellness Spa prides ... in Lakeway, Texas and will ... Duality laser. The medical spa is focused on helping ... laser procedures. Their addition of the Astanza Duality will ... their tattoo regret. "The large number of ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2
... Inc.,(Nasdaq: ENCO ), a full service multinational ... countries for many of the world,s,leading pharmaceutical and ... and Prologue have mutually agreed to postpone,negotiations regarding ... of the two companies have decided to form ...
... Helix BioPharma announced,today that it has received the ... to expand upon its clinical trial with Topical,Interferon ... presently,underway in Sweden., "We are pleased to ... said John Docherty, President of Helix BioPharma. "The,opening ...
Cached Medicine Technology:Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 2Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 3Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 4Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducers with guidewires....
Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
Medicine Products: